Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Acta otorrinolaringol. esp ; 71(5): 303-308, sept.-oct. 2020. graf
Artículo en Español | IBECS | ID: ibc-195217

RESUMEN

INTRODUCCIÓN: La rinosinusitis fúngica invasiva aguda (RSFIA) es una enfermedad poco frecuente, de alta mortalidad. Se presenta principalmente en pacientes inmunocomprometidos con múltiples comorbilidades, lo que dificulta su manejo. El objetivo de este trabajo es describir una cohorte de pacientes operados por RSFIA, sus características clínicas y mortalidad, los agentes etiológicos y el rendimiento de los métodos de diagnóstico. MATERIAL Y MÉTODO: Estudio prospectivo no concurrente de pacientes operados por RSFIA entre el 2005 y 2015 en nuestro centro. RESULTADOS: Se incluyeron 32 pacientes, 62,5% (20/32) hombres, con una edad promedio de 39,4 años (16-65 años). La mortalidad global fue del 71,9%, correspondiendo un 46,9% a mortalidad en agudo y un 25% a tardía. Las neoplasias hematológicas fueron la enfermedad de base más frecuente, correspondiendo al 84,4% (27/32) de los casos, seguida de la diabetes mellitus en un 9,4% (3/32). El 62,5% (20/32) de los pacientes presentó neutropenia al diagnóstico, y un 80% (16/20) de ellos, neutropenia febril. El síntoma más frecuente fue la fiebre en un 65,6% (21/32), luego dolor facial o cefalea en un 53,1% (17/32). Se identificó Aspergillus en el 37,5% (12/32), seguido por Rhizopus en el 31,3% (10/32). No se encontró asociación entre las variables estudiadas y un mayor riesgo de mortalidad. CONCLUSIONES: La RSFIA es una enfermedad agresiva con una alta mortalidad, siendo fundamental el diagnóstico oportuno. Es necesario optimizar los criterios de sospecha para un diagnóstico precoz que permita mejorar el pronóstico


INTRODUCTION: Acute invasive fungal rhinosinusitis (AIFRS) is rare but has high mortality. It is more frequent in immunocompromised patients with multiple comorbidities, which make their management more difficult. The aim of this study is to describe a cohort of patients operated due to AIFRS, their clinical characteristics, mortality, aetiological agent and efficacy of diagnostic tests. MATERIAL AND METHOD: Non-concurrent prospective study of patients with AIFRS who were operated between 2005 and 2015 in our centre. RESULTS: Thirty-two patients were included, 62.5% (20/32) men, with an average age of 39.4 years (16-65 years). Overall mortality was 71.9%; acute mortality 46.9% and late mortality 25%. Haematological malignancies were the most common underlying disease, present in 84.4% (27/32) of cases, followed by diabetes mellitus in 9.4% (3/32). On diagnosis, 62.5% (20/32) of patients were neutropenic, 80% (16/20) of them with febrile neutropenia. Fever was the most frequent symptom, present in 65.6% (21/32) of patients, followed by facial pain or headache in 53.1% (17/32). Aspergillus was identified in 37.5% (12/32) of cases and Rhizopus in 31.3% (10/32). There was no association between the analysed variables and increased risk of mortality. CONCLUSIONS: AIFRS is an aggressive disease with a high mortality rate, therefore a timely diagnosis is fundamental. It is necessary to optimise suspicion criteria for an early diagnosis in order to improve the prognosis


Asunto(s)
Humanos , Masculino , Femenino , Niño , Adolescente , Adulto Joven , Adulto , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Sinusitis/microbiología , Rinitis/microbiología , Sinusitis/cirugía , Rinitis/cirugía , Infecciones Fúngicas Invasoras/cirugía , Estudios Prospectivos , Enfermedad Aguda , Sinusitis/mortalidad , Rinitis/mortalidad , Infecciones Fúngicas Invasoras/mortalidad , Modelos Logísticos , Factores de Riesgo , Chile/epidemiología
2.
Artículo en Inglés, Español | MEDLINE | ID: mdl-32402378

RESUMEN

INTRODUCTION: Acute invasive fungal rhinosinusitis (AIFRS) is rare but has high mortality. It is more frequent in immunocompromised patients with multiple comorbidities, which make their management more difficult. The aim of this study is to describe a cohort of patients operated due to AIFRS, their clinical characteristics, mortality, aetiological agent and efficacy of diagnostic tests. MATERIAL AND METHOD: Non-concurrent prospective study of patients with AIFRS who were operated between 2005 and 2015 in our centre. RESULTS: Thirty-two patients were included, 62.5% (20/32) men, with an average age of 39.4 years (16-65 years). Overall mortality was 71.9%; acute mortality 46.9% and late mortality 25%. Haematological malignancies were the most common underlying disease, present in 84.4% (27/32) of cases, followed by diabetes mellitus in 9.4% (3/32). On diagnosis, 62.5% (20/32) of patients were neutropenic, 80% (16/20) of them with febrile neutropenia. Fever was the most frequent symptom, present in 65.6% (21/32) of patients, followed by facial pain or headache in 53.1% (17/32). Aspergillus was identified in 37.5% (12/32) of cases and Rhizopus in 31.3% (10/32). There was no association between the analysed variables and increased risk of mortality. CONCLUSIONS: AIFRS is an aggressive disease with a high mortality rate, therefore a timely diagnosis is fundamental. It is necessary to optimise suspicion criteria for an early diagnosis in order to improve the prognosis.


Asunto(s)
Infecciones Fúngicas Invasoras/cirugía , Rinitis/cirugía , Sinusitis/cirugía , Enfermedad Aguda , Adolescente , Adulto , Anciano , Antifúngicos/uso terapéutico , Aspergilosis/tratamiento farmacológico , Aspergilosis/cirugía , Aspergillus/aislamiento & purificación , Terapia Combinada , Complicaciones de la Diabetes/epidemiología , Diagnóstico Precoz , Neutropenia Febril/inducido químicamente , Neutropenia Febril/complicaciones , Femenino , Neoplasias Hematológicas/complicaciones , Humanos , Huésped Inmunocomprometido , Infecciones Fúngicas Invasoras/tratamiento farmacológico , Infecciones Fúngicas Invasoras/microbiología , Leucemia/complicaciones , Linfoma/complicaciones , Masculino , Persona de Mediana Edad , Mucormicosis/tratamiento farmacológico , Mucormicosis/cirugía , Infecciones Oportunistas/tratamiento farmacológico , Infecciones Oportunistas/microbiología , Infecciones Oportunistas/cirugía , Pronóstico , Estudios Prospectivos , Rinitis/tratamiento farmacológico , Rinitis/microbiología , Rhizopus/aislamiento & purificación , Factores de Riesgo , Sinusitis/tratamiento farmacológico , Sinusitis/microbiología , Adulto Joven
3.
Artículo en Inglés | MEDLINE | ID: mdl-29601150

RESUMEN

BACKGROUND: Spacers are inserted into the middle meatal space (MMS) following functional endoscopic sinus surgery (FESS) to prevent lateralization of the middle turbinate, scarring, and synechiae. Our objective was to determine if the incidence of postoperative synechiae, facial pain/discomfort, pain during spacer removal, scarring, and discharge differed between nasal cavities receiving Silastic or gloved-Merocel (GM) spacers following FESS. METHODS: A double-blind, randomized controlled trial (RCT) was conducted in adults requiring bilateral FESS for chronic rhinosinusitis (CRS) ± nasal polyposis. Participants served as their own controls, with each subject receiving both a Silastic and GM spacer. Spacers were inserted into the MMS during FESS and left in situ for 6 days. Participants were reviewed at 6 days, 5 weeks, and 12 weeks postoperatively. The presence of synechiae and scarring were evaluated endoscopically. Inflammation, discharge, and pain during spacer removal were assessed using a visual analogue scale (VAS). RESULTS: Forty-eight participants (96 nasal cavities) were recruited. Preoperatively, Lund-Mackay computed tomography (CT) scores were similar between Silastic-treated and GM-treated cavities (6.38 ± 2.35 vs 6.18 ± 2.17). The incidence of synechiae and scarring did not differ significantly between spacers up to 12 weeks postoperatively. Pain during spacer removal was significantly greater for Silastic than GM spacers (2.13 ± 1.34 vs 1.51 ± 1.23, p = 0.020). Facial pain prior to removal and extent of discharge did not differ significantly between spacers. CONCLUSION: Following FESS, patients report less pain during removal of GM than Silastic spacers. However, the likelihood of synechiae and scarring did not differ between either of the spacers.

4.
Int Forum Allergy Rhinol ; 7(5): 488-493, 2017 05.
Artículo en Inglés | MEDLINE | ID: mdl-28151588

RESUMEN

BACKGROUND: Although short-term use (≤2 months) of atomized topical nasal steroids has been shown to be safe and effective, the long-term safety has yet to be demonstrated. The aim of this study was to determine the impact of long-term topical budesonide treatment via the mucosal atomization device (MAD) on the hypothalamic-pituitary-adrenal axis (HPAA) and intraocular pressure (IOP). METHODS: A cross-sectional study of patients with chronic rhinosinusitis (CRS), with or without nasal polyposis, managed with daily nasal budesonide via MAD was conducted at a tertiary rhinology center. Patients using systemic steroids within 3 months of assessment were excluded. HPAA impact was assessed using the cosyntropin stimulation test for adrenal function and a survey of relevant symptomatology. Patients also underwent tonometry to assess for elevated IOP potentially related to corticosteroid use. RESULTS: A total of 100 CRS patients were recruited with a mean budesonide treatment duration of 23.5 months (range, 6-37 months). Stimulated cortisol response was diminished in 3 patients (3%). No patients with adrenal suppression had relevant symptomatology. IOP was elevated in 6 patients (6%). CONCLUSION: These findings suggest that there is a risk of adrenal suppression and raised IOP associated with the long-term use of topical nasal budesonide via MAD. Otolaryngologists should consider periodic surveillance for these adverse events in this patient cohort.


Asunto(s)
Antiinflamatorios/efectos adversos , Budesonida/efectos adversos , Glucocorticoides/efectos adversos , Sistema Hipotálamo-Hipofisario/efectos de los fármacos , Presión Intraocular/efectos de los fármacos , Sistema Hipófiso-Suprarrenal/efectos de los fármacos , Administración Intranasal , Anciano , Antiinflamatorios/administración & dosificación , Antiinflamatorios/uso terapéutico , Budesonida/administración & dosificación , Budesonida/uso terapéutico , Enfermedad Crónica , Femenino , Glucocorticoides/administración & dosificación , Glucocorticoides/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Pólipos Nasales/tratamiento farmacológico , Nebulizadores y Vaporizadores , Rinitis/tratamiento farmacológico , Sinusitis/tratamiento farmacológico
5.
Eur Arch Otorhinolaryngol ; 268(8): 1157-1162, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21400253

RESUMEN

Invasive fungal rhinosinusitis (IFR) is a complication that presents mainly in immunocompromised patients. Paranasal sinuses computed tomography (PCT) is frequently obtained during initial evaluation of suspected cases. The objective of the study was to determine the imaging findings that suggest IFR in patients with hematological malignancies. In the retrospective case/control study, we included 14 patients with hematological malignancies that developed IFR in the Hospital Clínico de la Pontificia Universidad Católica de Chile between January 2005 and June 2009. Twenty patients with hematological malignancies, with suspected sinonasal infectious involvement requiring a PCT for initial evaluation, were chosen as the control group. Thirteen imaging parameters were compared between both groups. Osseous erosion and facial soft tissue thickening were statistically associated with the presence of IFR (p < 0.05). The presence of osseous erosion, facial soft tissue thickening, extrasinus extension or unilateral involvement had a positive predictive value of 100%, with an incidence among the total group of 12, 15, 9 and 9%, respectively. No patients with IFR had a normal PCT. Most PCTs in the initial evaluation of suspected IFR had nonspecific findings. The clinician must have a high index of suspicion and complement the workup with other diagnostic techniques to initiate appropriate treatment.


Asunto(s)
Micosis/diagnóstico por imagen , Senos Paranasales/diagnóstico por imagen , Rinitis/diagnóstico por imagen , Sinusitis/diagnóstico por imagen , Tomografía Computarizada por Rayos X/métodos , Adolescente , Adulto , Anciano , Niño , Preescolar , Diagnóstico Diferencial , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Senos Paranasales/microbiología , Estudios Retrospectivos , Rinitis/complicaciones , Rinitis/microbiología , Sinusitis/complicaciones , Sinusitis/microbiología , Adulto Joven
6.
Pediatr. día ; 22(3): 35-38, jul.-ago. 2006.
Artículo en Español | LILACS | ID: lil-443394

RESUMEN

La dilatación de las venas del plexo pampiniforme es un problema médico que ya fue identificado hacia fines del siglo XIX. A pesar de esto, sus consecuencias en el tamaño testicular, parámetros seminales y el impacto en la fertilidad siguen siendo temas debatidos en forma activa en la literatura actual, apoyado principalmente en el desarrollo de nuevas técnicas de laboratorio, exámenes diagnósticos y procedimientos quirúrgicos mínimamente invasivos. Como resultado de esto, hay una serie de interrogantes acerca del varicocele adolescente que no han sido respondidas, principalmente en lo que respecta a la utilidad de realizar una corrección quirúrgica precoz para prevenir una eventual infertilidad futura.


Asunto(s)
Masculino , Adolescente , Humanos , Varicocele/cirugía , Varicocele/diagnóstico , Infertilidad Masculina/prevención & control , Signos y Síntomas , Varicocele/etiología , Varicocele/fisiopatología
7.
Neumol. pediátr ; 1(1): 6-10, 2006. tab
Artículo en Español | LILACS | ID: lil-498132

RESUMEN

La otitis media con efusión y la otitis media aguda son dos patologías frecuentes en la población pediátrica. Existen diversas medidas costo-fectivas para su manejo que permiten optimizar los resultados. Si bien muchas de estas conductas se practican diariamente, la evidencia en torno a ello es escasa y muchas veces débil. Nuevas áreas de investigación sugieren que el screening es una medida efectiva, permitiendo identificar a sujetos de mayor riesgo. El uso de nuevas vacunas no esta recomendado de manera rutinaria.


Asunto(s)
Humanos , Niño , Tamizaje Masivo , Otitis Media/diagnóstico , Otitis Media/prevención & control , Enfermedad Aguda , Algoritmos , Antibacterianos/uso terapéutico , Antagonistas de los Receptores Histamínicos H1 , Otitis Media con Derrame/diagnóstico , Otitis Media con Derrame/prevención & control , Otitis Media con Derrame/tratamiento farmacológico , Otitis Media/tratamiento farmacológico , Vacunas Neumococicas/uso terapéutico
8.
Pediatr. día ; 21(5): 42-46, nov.-dic. 2005.
Artículo en Español | LILACS | ID: lil-439422

RESUMEN

Este trabajo pretende dar una visión actualizada acerca de este problema, mediante una revisión de los trabajos de mayor relevancia publicados en la literatura, para intentar fundamentar la decisión de utilizar o no antibióticos en pacientes pediátricos que se presentan clínicamente con una OMA no complicada.


Asunto(s)
Humanos , Antibacterianos/uso terapéutico , Otitis Media/tratamiento farmacológico , Enfermedad Aguda , Antibacterianos/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...